These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36297368)

  • 21. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs.
    Bednarski M; Otto M; Dudek M; Kołaczkowski M; Bucki A; Siwek A; Groszek G; Maziarz E; Wilk P; Sapa J
    Arch Pharm (Weinheim); 2016 Mar; 349(3):211-23. PubMed ID: 26853441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.
    Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K
    Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo demonstration of alpha-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial alpha-adrenoceptors.
    Broadley KJ; Williamson KL; Roach AG
    J Auton Pharmacol; 1999 Feb; 19(1):55-63. PubMed ID: 10385270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
    Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
    Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Siwek A; Cegła M; Marona H
    Bioorg Med Chem; 2013 Jan; 21(2):514-22. PubMed ID: 23245804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
    Pytka K; Partyka A; Jastrzębska-Więsek M; Siwek A; Głuch-Lutwin M; Mordyl B; Kazek G; Rapacz A; Olczyk A; Gałuszka A; Błachuta M; Waszkielewicz A; Marona H; Sapa J; Filipek B; Wesołowska A
    PLoS One; 2015; 10(11):e0142499. PubMed ID: 26554929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.
    Kotańska M; Kulig K; Marcinkowska M; Bednarski M; Malawska K; Zaręba P
    J Endocrinol Invest; 2018 May; 41(5):609-619. PubMed ID: 29110282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional activation of Gα
    Odagaki Y; Kinoshita M; Ota T
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):567-574. PubMed ID: 30869808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats.
    Pytka K; Głuch-Lutwin M; Knutelska J; Jakubczyk M; Waszkielewicz A; Kotańska M
    PLoS One; 2016; 11(10):e0165495. PubMed ID: 27788267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological evidence that metformin blocks the vasopressor responses mediated by stimulation of α
    de la Cruz SH; Medina-Terol GJ; Beltrán-Ornelas JH; Gomez CB; Morato-Valderrama Y; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2018 Feb; 820():130-137. PubMed ID: 29248426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
    Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
    Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.